Introduction
Astrocyte elevated gene-1 (AEG-1) was cloned in our laboratory as a novel gene with elevated expression in primary human fetal astrocytes (PHFA) infected with human immunodeficiency virus type 1 (HIV-1) or treated with gp120 or tumor necrosis factor a (TNF-a) (Su et al., 2002 (Su et al., , 2003 . Intriguingly, AEG-1 is highly expressed in subsets of breast carcinomas, malignant gliomas and melanomas, and it synergizes with oncogenic Ha-ras to enhance soft agar colony formation of nontumorigenic immortalized melanocytes . Its expression is also elevated in adult astrocytes transformed by simian virus 40 (SV40) T/t, human telomerase reverse transcriptase (hTERT) and Ha-ras that display an aggressive glioma-like phenotype (Rich et al., 2001; Kang et al., 2005) . In addition, AEG-1 induces increased anchorage-independent growth and invasiveness of tumor cells and increased expression of adhesion molecules by activating the nuclear factorkappaB (NF-kB) signaling pathway. AEG-1 also interacts physically with p65 to modulate its function in the nucleus . Our recent results proved that AEG-1 is one of the downstream target genes of oncogenic Ha-ras and plays a critical role in Ha-ras-mediated oncogenesis (Lee et al., 2006) . Other studies have identified AEG-1 homologs in rat and mouse, named Lyric and Metadherin, respectively, and provided evidence for an involvement in cancer progression and metastasis (Britt et al., 2004; Brown and Ruoslahti, 2004; Sutherland et al., 2004) . In total, these observations indicate that AEG-1 may be a fundamental gene regulating cell transformation and tumor progression.
Human cancer involves a stepwise progression with accumulation of genetic and epigenetic alterations in oncogenes, tumor suppressor genes, tumor progression and metastasis promoting genes, and genome-stabilizing genes (Fisher, 1984; Vogelstein and Kinzler, 2004) . Different combinations of these alterations have been observed in human cancers and a number of these genes appear to be involved in distinct steps of neoplastic transformation (Fisher, 1984; Hanahan and Weinberg, 2000; Vogelstein and Kinzler, 2004) . Oncogene and tumor suppressor gene mutations might cooperate to drive the neoplastic process by increasing cell number through stimulation of cell proliferation or inhibition of cell death (Fisher, 1984; Hanahan and Weinberg, 2000; Evan and Vousden, 2001; Vogelstein and Kinzler, 2004) . The increase in cell number can be a consequence of activating genes that drive the cell cycle, inhibit normal apoptosis or facilitate the supply of nutrients through enhanced angiogenesis (Fisher, 1984; Hanahan and Weinberg, 2000; Evan and Vousden, 2001; Vogelstein and Kinzler, 2004) .
We documented previously that AEG-1 promotes Ha-rasinduced cell proliferation and invasiveness confirming cooperation with Ha-ras in mediating the transformed phenotype Lee et al., 2006; Emdad et al., 2007) . In the present study, we explored the effect of AEG-1 on serum-independent cell growth, a hallmark of oncogene action. Serum starvation-induced cell death was blocked by AEG-1 overexpression and this inhibition was mediated through phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathways. We also provide evidence for the existence of a positive feedback loop between AEG-1 and the PI3K-Akt signaling pathway. The present studies uncover a previously uncharacterized mechanism of signaling downstream of Ha-ras in tumorigenesis and delineate a critical role for AEG-1 in promoting cancer development and/or its maintenance. In this context, AEG-1 may provide a suitable target for therapeutic intervention of Ras-mediated pathogenesis.
Results

AEG-1 prevents serum starvation-induced cell death
To investigate the possible oncogenic roles of AEG-1, we analysed serum dependence and growth rate of PHFA, PHFA cells immortalized by hTERT (IM-PHFA), human adult astrocytes immortalized by hTERT and SV40 T/t (THV) and THV cells overexpressing Ha-ras (THR) cells infected with a recombinant replication-incompetent adenovirus expressing AEG-1 (Ad.AEG-1) or a control adenovirus (Ad.vec). Cell growth was quantified using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. AEG-1 did not significantly alter cell growth in any of the cell lines under normal growth conditions (complete medium containing 10% fetal bovine serum, FBS) ( Figure 1a , lower panel). However Ad.AEG-1-infected PHFA and IM-PHFA, but not THR cells, were more resistant to serum starvation (0.1% FBS)-induced inhibition of cell growth ( Figure 1a, upper panel) . The effect of AEG-1 expression in THV cells, although less than in PHFA or IM-PHFA, was also significant (Figure 1a , upper panel). Since both SV40 T/t and Haras facilitate serum-independent cell growth (Mulcahy et al., 1985; White et al., 1992; Hahn et al., 2002) , THV and THR cells already have the capacity to grow optimally under conditions of serum deprivation (Figure 1a) . These results were confirmed and extended using cloned rat embryo fibroblasts (CREF) (Fisher et al., 1982) , CREF stably overexpressing Ha-ras (CREF-ras), normal human melanocytes immortalized by SV40 T antigen (FM516) and FM516 cells overexpressing Ha-ras (FM516-ras) (Figures 1b and c) . AEG-1 significantly inhibited serum starvation-induced cell death in CREF and FM516 cells, but not in CREFras and FM516-ras cells (Figures 1b and c) , indicating that AEG-1 prevents serum starvation-induced cell death in normal cells, but not in Ras-transformed cells.
We recently reported that AEG-1 is a target gene of oncogenic Ha-ras (Lee et al., 2006) . Based on these results, we examined whether AEG-1 regulates cell growth downstream of Ha-ras under serum starvation conditions by using AEG-1 siRNA. As shown in Figure 1d , AEG-1 siRNA inhibited THR cell growth, but not that of IM-PHFA, under normal conditions or after serum starvation. Taken together, these results further confirm that AEG-1 is a downstream target gene of oncogenic Ha-ras and involved in promoting cell growth. Even though less effective in THR cells, AEG-1 siRNA also inhibited cell growth in THV cells (Figure 1d ), indicating that AEG-1 may also contribute to SV40-mediated cell growth.
PI3K-Akt signaling is involved in AEG-1-mediated cell survival To identify the intracellular signaling pathway by which AEG-1 induces cell survival under serum starvation conditions, a series of pharmacological inhibitors including LY294002 (PI3K inhibitor), PD98059 (MEK inhibitor), SP600125 (JNK inhibitor), SB302580 (p38 MAPK inhibitor) and Y27632 (Rho-kinase inhibitor) were used. Only LY294002 attenuated AEG-1-dependent cell growth of PHFA cells under serum-deprived culture conditions, with little effect under normal culture conditions (Figure 2a ), indicating that the PI3K signaling pathway, a key Ha-ras signaling pathway, mediates AEG-1-dependent protection against serum starvation.
While Akt, NF-kB and the mammalian target of rapamycin (mTOR) are downstream effectors of PI3K, the phosphatase and tensin homolog (PTEN) is a phosphatase antagonizing the diverse downstream signaling pathways activated by PI3K-derived phospholipids (Nicholson and Anderson, 2002; Franke et al., 2003; Downward, 2004; Osaki et al., 2004; Altomare and Testa, 2005) . To analyse the relative importance of PI3K signaling in serum starvation-induced cell death, recombinant replication-incompetent adenoviruses expressing PTEN (Ad.PTEN), dominant-negative AKT (Ad.DN-Akt) and mt32IkBa superrepressor (Ad.IkBa-mt32), as well as the pharmacological inhibitor rapamycin (mTOR inhibitor) were used. AEG-1-induced cell survival under serum starvation conditions was significantly inhibited by LY294002, Ad.DN-Akt and Ad.PTEN, but not by Ad.IkBa-mt32 or rapamycin (Figure 2b ). These results indicate that AEG-1-dependent cell growth is mediated via Akt signaling downstream of PI3K.
Akt kinase activity correlates with phosphorylation of Thr-308 (pT308) and . Both phosphorylation events are required to achieve maximal Akt activity (Franke et al., 2003; Osaki et al., 2004; Altomare and Testa, 2005) . Using phospho-specific antibodies, we found that AEG-1 expression led to increased phosphorylation of Akt at both sites under normal conditions and following serum starvation conditions ( Figure 3 ). AEG-1-dependent changes in Akt phosphorylation correlated well with data shown in Figure 2 . Only limited Akt phosphorylation was detected in Ad.vec-infected cells under normal conditions, which may be characteristic of primary astrocyte cells that have a population doubling time of B4 days. We also examined the downstream antiapoptotic substrates of Akt to clarify the molecular mechanisms underlying AEG-1-dependent enhanced cell growth under conditions of serum starvation. As shown in Figure 3 , AEG-1 expression induced phosphorylation of glycogen synthase kinase (GSK)3b. Concomitantly with phosphorylation-induced inactivation of GSK3b, c-Myc levels were increased and serum starvation-dependent p21/mda-6 expression was inhibited. Bad, a proapoptotic member of the Bcl-2 family (Willis and Adams, 2005) was phosphorylated in Ad.AEG-1-infected PHFA (Figure 3 ). In addition, AEG-1 induced phosphorylation of murine double minute 2 (MDM2), another substrate of Akt and a negative regulator of p53, under serum 4 cells/well in a 96-well plate) were transfected with control or AEG-1 siRNA (20 nM). One day after transfection, the cells were treated under conditions of serum starvation or in normal serum-containing media. Cell viability was determined by MTT assay 4 days after growth under conditions of serum starvation or in normal serum-containing media. Values in the graph are presented as percent ratios to that of the nontransfected IM-PHFA grown in normal serum-containing media. Data in the graphs are presented as mean7s.d. Asterisks indicate statistically significant differences between Ad.vec-and Ad.AEG-1-infected cells or control siRNA and AEG-1 siRNA-transfected cells for each cell line (Po0.01).
AEG-1 facilitates cell survival S-G Lee et al starvation conditions, but not under normal conditions (Figure 3) . Interestingly, the expression of p53 was reduced by AEG-1 when cells were grown both under normal and serum starvation conditions (Figure 3 ), suggesting that AEG-1 may directly regulate p53 expression in addition to its effects exerted via Akt-MDM2. This possibility is currently being investigated further. The phosphorylation of FKHR was not changed by AEG-1 (Figure 3 ). These results suggest that AEG-1-induced Akt signaling can modulate cell survival by phosphorylation of specific substrates including GSK3b/c-Myc, p21/mda-6, MDM2/p53 and Bad.
AEG-1 inhibits serum starvation-induced apoptosis in PHFA The balance between cell proliferation and cell death determines cellular growth. Induction of proliferation and inhibition of apoptosis, either by itself or in combination, can increase the number of viable cells.
Results described above demonstrate that AEG-1 could increase cell numbers under serum starvation conditions. To determine if the AEG-1 effects were due to apoptosis inhibition we analysed the induction of apoptosis by Annexin V binding and propidium iodide (PI) staining followed by fluorescent-activated cell sorting analysis. Both assays produced comparable results. Based on Annexin V staining, serum starvation-induced apoptosis (X20%) in PHFA (Figure 4a ). However, AEG-1 significantly attenuated serum starvation-induced apoptosis. Treatment with LY294002 or infection with Ad.DN-Akt blocked the antiapoptotic effect of AEG-1 (Figure 4a ), suggesting that AEG-1 promotes cell survival by inhibiting apoptosis via the PI3K-Akt signaling pathway. Measurements of cells in the sub-G 0 population (A 0 ), containing a hypodiploid DNA content (another indicator of apoptosis), corroborated the data obtained with Annexin V staining (Figure 4b ). We also investigated the effects of AEG-1 expression on the activity of caspases (3/7 and 9), which mediate the induction and execution of apoptosis (Kumar, 2007) . AEG-1 inhibited serum starvation-induced activation of these caspases (Figures 4c and d) . In sum, these results indicate that AEG-1 promotes cell survival via antiapoptotic PI3K-Akt signaling ( Figure 5 ).
Discussion
Acquisition of tumorigenic and metastatic potential by an evolving cancer cell is a complex process involving a dynamic interplay between multiple genes that elicit changes in discrete signal transduction pathways. The 
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consequences of this plethora of biochemical changes are a loss of response to normal growth inhibitory cues, acquisition of potentially unlimited growth potential and resistance to apoptosis. In the present study, further evidence is provided that AEG-1 functions as an oncogene. We demonstrate that AEG-1 potentiates serum-independent cell growth by inhibiting apoptosis. AEG-1 abrogates serum starvation induced cell death in PHFA, IM-PHFA, THV, CREF and FM516 cells, but not in oncogenic Ha-ras-expressing cells (THR, CREFras and FM516-ras) (Figure 1 ). AEG-1 siRNA blocks serum-independent cell growth in THR cells, but not in IM-PHFA cells. These results indicate that AEG-1 plays a crucial role in oncogenic Ha-ras-mediated cell survival under suboptimal growth conditions.
Since AEG-1 is functionally correlated with Ha-ras Lee et al., 2006) , we used pharmacological inhibitors to block signaling downstream of Ras to define the molecular mechanism of AEG-1-induced enhancement in cell survival. Interestingly, we found that the PI3K-Akt signaling pathway is involved in AEG-1-mediated protection against serum starvation-induced cell death (Figure 2 ). These results, together with our previous data, indicate that AEG-1 not only cooperates with Ha-ras but also serves as a downstream target of Ha-ras in regulating both cell proliferation and survival.
Analysis of the effect of AEG-1 overexpression on downstream signaling molecules of the Akt pathway involved in cell growth and survival revealed that AEG-1-induced phosphorylation of GSK3b, Bad and MDM2, increased c-Myc expression, and decreased p53 and p21/ mda-6 expression (Figure 3) . Akt is known to stabilize c-Myc through phosphorylation and inactivation of GSK3b and also to promote transcriptional activation of c-myc (Chen and Sytkowski, 2001; Gregory et al., 2003; Bader et al., 2005) . The c-Myc gene is a master regulator of G 1 cell cycle checkpoint and induction of c-Myc by AEG-1 might provide a proliferative advantage under serum starvation conditions. Akt also regulates the apoptotic machinery by phosphorylating and inactivating the proapoptotic protein Bad that controls the release of cytochrome c from mitochondria (Franke and Cantley, 1997) .
Interestingly, Akt indirectly regulates the tumor suppressor p53 protein, which acts as a sensor for cellular stress and transduces the stress signals into apoptotic signals (Evan and Vousden, 2001 ). Akt phosphorylates MDM-2 protein and promotes its translocation into the nucleus and destabilization of p53 (Mayo and Donner, 2001; Zhou et al., 2001b) . By promoting the degradation of p53, Akt impairs the cellular stress response thus increasing cell survival (Mayo and Donner, 2001; Zhou et al., 2001b) . In addition, recent reports indicate that Akt can directly phosphorylate and inactivate p21/mda-6 (Jiang et al., 1995) , a p53-responsive gene (Rossig et al., 2001; Zhou et al., 2001a; Li et al., 2002) . As a cyclin-dependent kinase inhibitor, p21/mda-6 plays an essential role in keeping cell cycle in check. Downregulation of p21/mda-6 by AEG-1 provides another important level of survival advantage to cells under stressful conditions. Akt also exerts indirect control of apoptosis through regulation of transcription. Phosphorylation of the forkhead family of transcription factors (AFX, FKHR and FKHRL1) by Akt inhibits transcription of proapoptotic genes such as FasL, IGFBP-1 and Bim (Datta et al., 1999; Nicholson and Anderson, 2002) . In our studies, AEG-1 did not induce phosphorylation of FKHR (Figure 3 ). In addition, Akt can phosphorylate and activate IkB kinase a, which, in turn, phosphorylates IkB, targeting it for degradation (Kane et al., 1999; Ozes et al., 1999) . Degradation of IkB leads to the nuclear translocation and activation of NF-kB, and transcription of NF-kB-dependent prosurvival genes, including Bcl-X L , caspase inhibitors and c-Myb (Barkett and Gilmore, 1999; Lauder et al., 2001) . We also reported that AEG-1 interacts with p65 and activates the NF-kB pathway . However, the NF-kB signaling pathway was not involved in AEG-1-dependent cell survival under serum-limiting conditions (Figure 2b) . Additionally, we also document that AEG-1 inhibits the activity of caspases 3/7 and 9 resulting in serum starvation-induced apoptosis via the PI3K-Akt pathway (Figure 4) .
The present results suggest that AEG-1 induces serum-independent cell growth by blocking serum starvation-induced apoptosis through PI3K-Akt Figure 3 Astrocyte elevated gene-1 (AEG-1) regulates downstream substrates of Akt. PHFA cells were infected with Ad.vec or Ad.AEG-1 (20 PFU/cell). One day after infection, the cells were grown under serum starvation conditions (S) or in normal serumcontaining media (N). Cell lysates were prepared 1 day after growth in reduced serum (S) or in normal serum-containing media (N) and immunoblotted with the indicated antibodies.
AEG-1 facilitates cell survival S-G Lee et al signaling pathways and downstream signaling molecules of Akt including GSK3b-Myc, Bad, MDM2-p53 and p21/mda-6, which cause inhibition of caspase activities ( Figure 5 ). All of these results establish Akt signaling as one of the primary mediators of AEG-1-enhanced cell survival under serum starvation conditions. Previous studies demonstrate that Ha-ras induces AEG-1 expression through the PI3K-Akt signaling pathway (Lee et al., 2006) and that AEG-1 induces NF-kB signal-mediated tumor cell migration and invasion . Therefore, a positive feedback loop between AEG-1 and Ras through PI3K-Akt signaling pathways might exist that could potentially amplify the effect of each pathway independently, together with NF-kB signaling, toward tumor promotion and progression ( Figure 5 ). Increased insights into the detailed molecular mechanism of AEG-1 function and regulation will help clarify its role in the process of tumorigenesis and facilitate development of therapeutic strategies that target AEG-1 for extinction in cancers having activated Ras, a common event in multiple human cancers such as colorectal, thyroid and pancreatic tumors (Downward, 2003) .
Materials and methods
Cell cultures and reagents
Primary human fetal astrocyte cells were generated from human fetal brain tissue obtained from the products of elective abortions in full compliance with NIH guidelines, and were kindly provided by Dr Volsky and colleagues (Su et al., 2002 (Su et al., , 2003 . PHFA, IM-PHFA, FM516 and FM516-ras cells were cultured as described . THV, THR, CREF and CREF-ras cells were previously described (Rich et al., 2001; Lee et al., 2006) . LY294002, PD98059, SP600125, SB302580, Y27632 and rapamycin were purchased from Calbiochem (San Diego, CA, USA). Growth medium consisted of F12-Dulbecco's modified Eagle's medium supplemented with 10% FBS (normal) or 0.1% FBS (serum starvation).
Recombinant adenovirus constructs and siRNA
The recombinant replication-incompetent Ad.PTEN were created in two steps as previously described and plaque purified by standard procedures (Jiang et al., 1996; Emdad et al., 2006) . Ad.AEG-1 and Ad.IkBa-mt32 were previously described . The recombinant replication-deficient Ad.DN-Akt was generated by inserting a kinase-inactive One day after infection, cells were serum starved or grown in normal serumcontaining media. After 1 day, the activity of caspase-9 was measured as described in the 'Materials and methods' section. (d) Lysates were prepared as described in (c), and the activities of caspase-3/7 were measured. Values in the graphs are presented as percent ratios to that of the uninfected PHFA grown in normal serum-containing media taken as 100%. Data in the graphs are presented as mean7s.d.
AEG-1 facilitates cell survival S-G Lee et al mutant of mouse Akt (Franke et al., 1995) into the pAd.CMV5 retroviral vector. Amplification and purification of recombinant adenovirus was performed as previously described (Jiang et al., 1996) . The control and AEG-1 siRNAs were previously described (Lee et al., 2006) . The transfection of siRNA was performed using Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
MTT viability assays
Viability assays were performed as previously described (Lebedeva et al., 2007) . Briefly, cells were seeded in 96-well plates 5 Â 10 3 cells/well for PHFA cells or 1.5 Â 10 3 cells/well for other cell lines) and infected the next day with different adenoviruses. One day after infection, the cells were treated with normal FBS (10%) containing medium or reduced FBS (0.1%) medium with or without the indicated pharmacological inhibitors. After 4 days, the medium was removed, and fresh medium containing 0.5 mg/ml MTT was added to each well. The cells were incubated at 371C for 4 h and then an equal volume of solubilization solution (0.01 N HCl in 10% sodium dodecyl sulfate) was added to each well. The absorbance from the plates was read on a Bio-Rad Microplate Reader Model 550 at 595 nm. A Student's two-sample t-test, assuming unequal variances, was used to determine the equality of the means of two samples.
Preparation of cell extracts and western blotting analysis
Whole cell lysates were prepared and western blotting was performed as previously described (Lee et al., 2006) . The antibodies for AEG-1, EF1a, Akt, phospho-Akt (S473), GSK3b, phospho-GSK3b and c-Myc were previously described (Lee et al., 2006) . The antibodies for phospho-Akt (T308), phospho-Bad (S136), Bad and phospho-MDM2 were purchased from Cell Signaling Technology Inc. (Danvers, MA, USA). The antibody for MDM2 was purchased from Sigma (St Louis, MO, USA), and antibodies for p53, p21/mda-6, phospho-FKHR (S256) and FKHR were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Annexin V binding assay, hypodiploidy analysis and caspase activity assay Annexin V binding assay and hypodiploidy analysis were performed as previously described (Lebedeva et al., 2007) . Caspase 3, 7 and 9 activities in PHFA were measured using Caspases-Glo 3/7 Assay and Caspase-Glo 9 Assay kits (Promega, Madison, MI, USA) according to the manufacturer's instructions.
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Figure 5 A hypothetical model of the signal transduction pathways involved in the feedback loop between astrocyte elevated gene-1 (AEG-1) and the phosphatidylinositol 3-kinase (PI3K)-Akt pathway. Ha-ras activates the PI3K signaling cascade, resulting in increased AEG-1 expression, and AEG-1 activates the nuclear factor-kappa B (NF-kB) pathway that regulates expression of genes involved in migration and invasion. AEG-1-activated PI3K-Akt pathway inhibits apoptosis through phosphorylation of antiapoptotic Akt substrates including glycogen synthase kinase 3b (GSK3b), c-Myc, Bad, murine double minute 2 (MDM2), p53 and p21/mda-6.
